Contreras A, Carrasco L
J Virol. 1979 Jan;29(1):114-22. doi: 10.1128/JVI.29.1.114-122.1979.
A number of translation inhibitors were tested for their effects on both control and encephalomyocarditis virus-infected mouse 3T6 cells. The virus-infected cells were specifically inhibited by gougerotin, edeine, and blasticidin S, whereas these drugs failed to penetrate into uninfected cells. Inhibition of infected cells by gougerotin became apparent when the synthesis of viral proteins commenced, suggesting that the latter process is accompanied by a permeability change in the cells that allows uptake of the drug. This permeability change was not observed in cells treated with cycloheximide soon after viral infection, although treatment with actinomycin D did not prevent inhibition of gougerotin. It is possible, therefore, that a specific viral protein is involved in the permeability change of the plasma membrane. Moreover, gougerotin was unable to inhibit protein synthesis in the presence of zinc ions, thus preventing gougerotin from entering into the infected cell. Membrane leakiness was not restricted to the encephalomyocarditis virus-3T6 system; it was also observed in mengovirus-infected 3T6 cells, Semliki Forest virus-infected BHK cells, and simian virus 40-infected CVI1 cells at the time in which the synthesis of late proteins is maximal.
测试了多种翻译抑制剂对对照小鼠和脑心肌炎病毒感染的小鼠3T6细胞的影响。病毒感染的细胞被谷氏菌素、伊短菌素和杀稻瘟菌素S特异性抑制,而这些药物无法进入未感染的细胞。当病毒蛋白开始合成时,谷氏菌素对感染细胞的抑制作用变得明显,这表明后一过程伴随着细胞通透性的变化,从而使药物能够进入细胞。病毒感染后不久用环己酰亚胺处理的细胞未观察到这种通透性变化,尽管用放线菌素D处理并不能阻止谷氏菌素的抑制作用。因此,可能是一种特定的病毒蛋白参与了质膜的通透性变化。此外,在存在锌离子的情况下,谷氏菌素无法抑制蛋白质合成,从而阻止谷氏菌素进入感染细胞。膜渗漏并不局限于脑心肌炎病毒-3T6系统;在晚期蛋白合成达到最大值时,在感染脑脊髓炎病毒的3T6细胞、感染Semliki森林病毒的BHK细胞和感染猿猴病毒40的CVI1细胞中也观察到了这种情况。